FindTrial
Sign In

To find out echocardiographic (use of ultrasound to investigate the actions of heart) parameter to say which can develop post reperfusion syndrome (complication that may develop during organ transplant) during liver transplant.

Intraoperative Transesophageal echo-cardiographic parameters to predict Post Reperfusion Syndrome during Living Donor Liver Transplantation: A Prospective Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/03/041168
Enrollment
50
Registered
2022-03-17
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K77- Liver disorders in diseases classified elsewhere Health Condition 2: K746- Other and unspecified cirrhosis ofliver

Interventions

None listed

Sponsors

Institute of liver and biliary sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients undergoing LDLT in whom transesophageal echocardiography probe will be inserted Age > 18 years

Exclusion criteria

Exclusion criteria: Patient refusal Patients undergoing double transplant at same setting. Patients with Acute Liver Failure Previous history of oesophageal pathology (esophageal stricture, cancer, diverticulum, laceration, > grade 3 oesophageal varices, Gastric varices, active esophagitis) or recent esophageal surgery. History of recent ( < 1 month) upper gastro-intestinal bleed.

Design outcomes

Primary

MeasureTime frame
Transesophageal echocardiographic parameter to predict post reperfusion syndrome during living donor liver transplantationTimepoint: Baseline after induction 10 minutes after reperfusion After abdominal closure—

Secondary

MeasureTime frame
Transesophageal echocardiographic parameter to predict time to achieve hemodynamic stabilityTimepoint: Baseline after induction 10 minutes after reperfusion After abdominal closure—

Countries

India

Contacts

Public ContactDr Vaishali Agarwal

Institute of liver and biliary sciences

drsindwani25@gmail.com8728089898

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026